Ke Cheng

Jan 24, 2022

Historic NC State Veterinary Medicine Fundraising Campaign Exceeds Goal

The resounding success of the Think and Do the Extraordinary Campaign solidifies NC State University's position as a world leader in veterinary medicine.  

Jul 6, 2021

Three NC State Veterinary Medicine Faculty Members Awarded NIH Training Grants

The NIH grants will support interdisciplinary team science training of graduate students.  

Jun 30, 2021

NC State Veterinary Medicine News and Updates, June 2021

All the highlights from a busy month on campus. 

Jun 18, 2021

‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus

Research led by the CVM's Ke Cheng shows that nanodecoys can bind to SARS-CoV-2, helping clear the virus faster. 

Apr 20, 2021

Reopen and Regenerate: Exosome-Coated Stent Heals Vascular Injury, Repairs Damaged Tissue

The stent has a “smart-release” trigger that could both prevent reopened blood vessels from narrowing and deliver regenerative stem cell-derived therapy to tissue. 

Mar 10, 2021

Pericardial Injection Effective, Less Invasive Way to Get Regenerative Therapies to Heart

Injecting hydrogels containing stem cell or exosome therapeutics directly into the pericardial cavity could be a more effective means of treating cardiac injury, according to CVM-led research. 

Feb 2, 2021

CVM-Led Contraceptive Gel Project Combines Spermicidal, Anti-Viral, Libido-Enhancing Agents

“The trifunctional contraceptive gel we created yielded higher contraceptive success rates than those on the market,” says the CVM's Ke Cheng. 

Jan 13, 2021

Meurs Receives Distinguished Professorship in Comparative Medicine

Meurs’ ongoing, groundbreaking research broadens understanding of cardiac genetic disease in companion animals, information that often has potential to guide treatment of human disease. 

Mar 2, 2020

Inhalation Therapy Shows Promise Against Pulmonary Fibrosis

The research could lead to more effective, less invasive treatments for human pulmonary fibrosis sufferers. 

Feb 6, 2020

Platelet Microparticles Give Antibody Drug ‘Piggyback Ride’ to Repair Damaged Heart

New CVM research shows that platelet microparticles can effectively deliver therapeutic drugs directly to the heart following a heart attack.